Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study Assessing the Acceptability, Adherence, and Safety of Photobiomodulation (PBM) Therapy and Objective Assessment Measures in Myalgic Encephalomyelitis (ME)

NCT06145867 is registered in ClinicalTrials.gov with Quadram Institute Bioscience as lead sponsor.

NCT NCT06145867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06145867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study Assessing the Acceptability, Adherence, and Safety of Photobiomodulation (PBM) Therapy and Objective Assessment Measures in Myalgic Encephalomyelitis (ME)
Lead sponsor
Quadram Institute Bioscience
Phase
Not applicable
Overall status
Unknown status
Start date
April 24, 2024
Completion date
August 1, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue syndrome, myalgic encephalomyelitis